Ugur Sahin The founder and CEO of Biontech talks about his successes, visions – and bureaucracy. – (Foto: imago images/Political-Moments) – – – – Mainz The warnings of increasing numbers of corona infections due to the new variant BA.5 are getting louder. However, Biontech boss Ugur Sahin believes that a wave in the summer, if it … Read more
Award for Katalin Karikó, Özlem Türeci and Uğur Şahin The vaccine from the Mainz company Biontech was one of the first corona vaccines. Now the biochemist Katalin Karikó and the Biontech founders Özlem Türeci and Ugur Sahin have been awarded the renowned Paul Ehrlich and Ludwig Darmstaedter Prize for their research on mRNA vaccines. Jochen … Read more
can we already booster shots distribute and vaccinate young children, when in some countries hardly anyone is protected against the corona virus? “By 2022 there will be enough vaccines to vaccinate the whole world,” said Ugur Sahin of BioNTech. A year ago we did not know whether a vaccine would come on the market, now … Read more
:quality(90)/cloudfront-us-east-1.images.arcpublishing.com/lanacionpy/GFFO526TUNE43LLLJU4JG5ZIOI.jpg?fit=%2C&ssl=1)
This Tuesday morning, 140,000 doses of AstraZeneca vaccines arrived in the country. Said batch comes from Spain, bought by the National Government from the European country. Said batch will be used to complete the vaccination schedule of the people who received the first dose with the anticovid immunological. Héctor Castro, director of the Expanded Immunization … Read more
BioNTech, a German maker of the COVID-19 vaccine, predicts that existing technology can be used. A new vaccine was produced to tackle the new strain of COVID in 6 weeks. Ugur Sahin CEO BioNTech, photo from BioNTech BioNTech CEO Ugur Sahin said he thinks the company can use the existing COVID-19 vaccine, developed with Pfizer, … Read more
The stock market rally driven by the promising results of Pfizer’s Covid-19 vaccine trial increased the fortunes of many investors, but nothing compared to that recorded by brothers Andreas and Thomas Struengmann, from Germany. Together, the twins increased their assets by $ 8 billion this year due to their participation in BioNTech, Pfizer’s partner in … Read more